As expected, this result produced a promising strategy to improve chemosensitivity and prognosis in gastric cancer by stimulating autophagy of ARHGAP5-AS1 or destabilizing ARHGAP5 caused by METTL3 removal [127]. This evidence concerns the gene METTL3 and gastric cancer.